Respiratory tract infections, bacterial

Cefuroxime is indicated to treat infections of bacterial origin such as urinary tract infections, otitis media and upper respiratory tract infections. Bacterial vaginosis is likely to be treated with metronidazole and clindamycin. 

Increased in bacterial infections such as pneumonia, upper respiratory tract infection, bacterial meningitis, tonsillitis, gastroenteritis, enterocolitis, streptococcal infection, mononucleosis, lymphadenitis, conjunctivitis, and whooping cough. 

Levalbuterol may be utilized if the patient experiences tachycardia or tremors with albuterol ° Antimicrobials should be reserved for patients with evidence of a bacterial respiratory tract infection... 

O Antibiotic resistance patterns affect treatment options for bacterial upper respiratory tract infections. 

Proper diagnosis of bacterial upper respiratory tract infections is crucial to identify patients who require antibiotics to avoid unnecessary antibiotic use. 

Upper respiratory tract infection (URI) is a term that refers to various upper airway infections, including otitis media, sinusitis, pharyngitis, and rhinitis. Most URIs are viral and often selflimited. Over 1 billion viral URIs occur annually in the United States, resulting in millions of physician office visits each year.1 Excessive antibiotic use for URIs has contributed to the significant development of bacterial resistance. Guidelines have been established to reduce inappropriate antibiotic use for viral URIs.2 This chapter will focus on acute otitis media, sinusitis, and pharyngitis because they are frequently caused by bacteria and require appropriate antibiotic therapy to minimize complications. 

Streptococcus pneumoniae is the most common bacterial cause of community-acquired respiratory tract infections. S. pneumoniae causes approximately 3000 cases of meningitis, 50,000 cases of bacteremia, 500,000 cases of pneumonia, and over 1 million cases of otitis media each year. The increasing prevalence of drug-resistant S. pneumoniae has highlighted the need to prevent infection through vaccination. Both licensed pneumococcal vaccines are highly effective in preventing disease from the common S. pneumoniae serotypes that cause human disease. 

Upper respiratory tract infection Sinusitis, bronchitis, or otitis caused by viral or bacterial infections. 

As outlined in the excellent review by Gilles and Brogden [9], the current indications for rifaximin include surgical prophylaxis and the treatment of hepatic encephalopathy, infectious diarrhea and intestinal bacterial overgrowth syndromes. As such, rifaximin is aimed only at enteric flora. Owing to its lack of absorption, rifaximin will likely not be used for other conditions or indications. Such limited indications should help preserve the activity of the agent, since overuse for common conditions like urinary or respiratory tract infections will naturally not occur. Limited use should help retard the development of resistance among enteric flora. 

Acute bacterial otitis media usually follows a viral upper respiratory tract infection that causes eustachian tube dysfunction and mucosal swelling in the middle ear. 

Also occurrence of cough may indicate a bacterial respiratory tract infection that requires antibacterial therapy. Patients who are receiving methotrexate may experience a drop in white-cell count, making them more susceptible to infections. 

Ceftizoxime is used for bacterial infections of the lower respiratory tract, infections of the urinary tract, infections of the bones, joints, skin, soft tissues, and abdominal infections. Synonyms of this drug are ceftix and eposerin. 

Bacterial septicemia, respiratory tract infections, skin and soft tissue infections, intra-abdominal Infections and infections of the female pelvis and genital tract... 

As most acute upper respiratory tract infections are not of bacterial origin, antibiotics are not often necessary in cases of acute pharyngitis and sinusitis. Supportive measures such as aerosols or rinsing with sterile saline and antipyretics are often sufficient. 

It contains Thujone, which could be toxic. Native Americans used thuja for malaria, gout, scurvy, rheumatism, menstrual disorders, and coughs. Thuja s volatile oil acts as a stimulant, a diuretic, and an irritant. Thuja is used for respiratory tract infections and in conjunction with antibiotics in the treatment of bacterial skin infections and Herpes simplex. 

Oral bioavailability is 57%, and tissue and intracallular penetration is generally good. Telithromycin is metabolized in the liver and eliminated by a combination of biliary and urinary routes of excretion. It is administered as a once-daily dose of 800 mg, which results in peak serum concentrations of approximately 2 g/mL. Telithromycin is indicated for treatment of respiratory tract infections, including community-acquired bacterial pneumonia, acute exacerbations of chronic bronchitis, sinusitis, and streptococcal pharyngitis. Telithromycin is a reversible inhibitor of the CYP3A4 enzyme system. 

Moxifloxacin has been approved as an anti-infective for the treatment of respiratory tract infections (CAP, AECB, ABS) and skin and soft tissue infections, and was launched in 1999. In the ophthalmological sector, it is used to treat bacterial eye infections. 

Cethromycin (ABT-773) 39 (Advanced Life Sciences) had an NDA filed in October 2008 for the treatment of CAP.67 Advanced Life Sciences is also evaluating cethromycin 39 against other respiratory tract infections and in pre-clinical studies as a prophylactic treatment of anthrax post-exposure. Cethromycin 3968 70 is a semi-synthetic ketolide derivative of erythromycin 4071 originally synthesised by Abbott Laboratories,72 which like erythromycin 40, inhibits bacterial protein synthesis through binding to the peptidyl-transferase site of the bacterial 50S ribosomal subunit. Important macrolide antibiotics in clinical use today include erythromycin 40 itself, clarithromycin, azithromycin and, most recently, telithromycin (launched in 2001). 

Respiratory Tract Infections, Upper CHAPTER 44 I Approach to Treatment of Acute Bacterial Sinusitis... 

S. pneumoniae is a common cause of acute bacterial conjunctivitis in children (Figure 25-5). Concurrent upper respiratory tract infections and otitis media, especially in children younger than 4 years, are common. In moderate climates S. pneumoniae is often the cause of acute bacterial conjunctivitis epidemics. This condition commonly presents with diffusely scattered petechial hemorrhages, especially on the superior bulbar conjunctiva, a mucopurulent discharge in the lower fornix, and transient marginal corneal infiltrates. Pseudomembranes may form. 

Sulfonamides maintain a significant role even today, because they are often used in combination with other antibacterials. For example, trimethyoprim, 35, has a diaminopyrimidine structure that has proved to be a highly selective, orally active, antibacterial, and antimalarial agent [6]. Trimethyoprim is combined to sulfamethoxazole, 36, for the treatment of bacterial respiratory tract infections and gastrointestinal infections [9]. 

Antimicrobials are over prescribed for exacerbations of asthma. Respiratory tract infections do cause increased airflow obstruction and hyperresponsiveness, but viral rather than bacterial pathogens are the commonest culprits. Antimicrobials should be prescribed only if there is high suspicion of a bacterial respiratory tract infection, e.g. purulent sputum. Note that macrolide antibiotics, such as erythromycin and clarithromycin, interfere with theophylline metabolism. 

Certain problems are peculiar to the use of wet nebuliza-tion inhalation devices. There is a risk of contamination of the airways with bacterial flora, which increases when treatment is given in a hospital (SEDA-2, 154). In one series of 41 patients in an intensive care unit who were being ventilated and were receiving nebulized salbutamol, all developed respiratory tract infections due to Burkholderia (Pseudomonas). The same organism (confirmed by molecular fingerprinting) was isolated from nebulizers and a multiple-dose bottle of salbutamol used for several of the patients. Appropriate infection control measures resolved the problem (SEDA-20,185). 

The answer is a. (Murray, pp 452-467. Scriver, pp 3-45. Sack, pp 1-40. Wilson, pp 101—120.) Virulent strains of bacteria that cause severe, life-threatening respiratory tract infections can often be successfully treated with erythromycin. These include Mycoplasma pneumoniae, various Legionella species, and Bordetella pertussis. The mechanism of action of erythromycin is to specifically bind the 50S subunit of bacterial ribosomes. Under normal conditions, after mRNA attaches to the initiation site of the 30S subunit, the 50S subunit binds to the 30S complex and forms the 70S complex that allows protein chain elongation to go forward. Elongation is prevented in the presence of erythromycin. 

---